Matches in Nanopublications for { ?s ?p "[Polymorphism A1166C contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy/mutated receptor has changed sensitivity to Angiotensine II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP135824.RAVnrXf30AJvzikPn9mC8toTljU-vbBJa5sTdL4H6xcbE130_assertion description "[Polymorphism A1166C contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy/mutated receptor has changed sensitivity to Angiotensine II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135824.RAVnrXf30AJvzikPn9mC8toTljU-vbBJa5sTdL4H6xcbE130_provenance.
- NP144162.RAZxfarGvGCBaIZCihgXKYYLgjutPNTjrCZnP0YPS6dpU130_assertion description "[Polymorphism A1166C contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy/mutated receptor has changed sensitivity to Angiotensine II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP144162.RAZxfarGvGCBaIZCihgXKYYLgjutPNTjrCZnP0YPS6dpU130_provenance.
- assertion description "[Polymorphism A1166C contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy/mutated receptor has changed sensitivity to Angiotensine II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Polymorphism A1166C contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy/mutated receptor has changed sensitivity to Angiotensine II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP198979.RABjiT0CZJKQuHtHDEUmi1Ns4lObjckQ5ZOJvMsT_phqE130_assertion description "[Polymorphism A1166C contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy/mutated receptor has changed sensitivity to Angiotensine II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP198979.RABjiT0CZJKQuHtHDEUmi1Ns4lObjckQ5ZOJvMsT_phqE130_provenance.
- NP207303.RA6Fzrpk9dtzEuU964aNojieA7tgR437P52MEJxdrYNk0130_assertion description "[Polymorphism A1166C contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy/mutated receptor has changed sensitivity to Angiotensine II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207303.RA6Fzrpk9dtzEuU964aNojieA7tgR437P52MEJxdrYNk0130_provenance.
- NP221412.RAxUE8LdkGQqTx-A6H0GJvBeJAZTorJ8-NavE9fimdEqI130_assertion description "[Polymorphism A1166C contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy/mutated receptor has changed sensitivity to Angiotensine II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221412.RAxUE8LdkGQqTx-A6H0GJvBeJAZTorJ8-NavE9fimdEqI130_provenance.
- NP221413.RAK67u--kRUIfhii54HfeM0FhD3KCMmSscEEtAbG-0mUg130_assertion description "[Polymorphism A1166C contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy/mutated receptor has changed sensitivity to Angiotensine II.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221413.RAK67u--kRUIfhii54HfeM0FhD3KCMmSscEEtAbG-0mUg130_provenance.